Donanemab Slows Progression in Early Alzheimer's
Safety issues linger, as details of three deaths emerge
Source: medpagetoday.com
Page 31 - John Sims News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Sims. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Sims Today - Breaking & Trending Today
Second Alzheimer's drug in the pipeline promises to slow worsening but with safety concern | Science & Tech
Patients given monthly infusions of Eli Lilly and Co.’s donanemab declined about four to seven months more slowly than those given dummy infusions in a large study
Source: elpais.com
Alzheimer's treatments: Second drug in pipeline can slow disease by months but with safety risk
Eli Lilly and Co is seeking Food and Drug Administration approval of donanemab. If cleared, it would be onl...
Source: 9news.com.au
Eli Lilly's Alzheimer's drug slows memory decline, study shows
Patients given monthly infusions of Eli Lilly and Co.'s donanemab declined about four to seven months more slowly than those given dummy infusions in a large...
Source: nbcnewyork.com
Second Alzheimer's drug in pipeline can slow the diseas...
New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening
Source: accesswdun.com